These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 18231949)
1. On the road to gene therapy for beta-thalassemia and sickle cell anemia. Bank A Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia. Sadelain M Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956 [TBL] [Abstract][Full Text] [Related]
3. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease. Sadelain M Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924 [No Abstract] [Full Text] [Related]
4. Gene therapy for hemoglobinopathies: are we there yet? Puthenveetil G; Malik P Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560 [TBL] [Abstract][Full Text] [Related]
5. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Bank A; Dorazio R; Leboulch P Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679 [TBL] [Abstract][Full Text] [Related]
6. Towards gene therapy of hemoglobinopathies. Beuzard Y Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584 [No Abstract] [Full Text] [Related]
7. Hemoglobin gene therapy for β-thalassemia. Bank A Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288 [TBL] [Abstract][Full Text] [Related]
8. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease. Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for the hemoglobin disorders. Persons DA; Nienhuis AW Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333 [TBL] [Abstract][Full Text] [Related]
10. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease. Lebensburger J; Persons DA Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610 [TBL] [Abstract][Full Text] [Related]
11. Future prospects for treatment of hemoglobinopathies. Stamatoyannopoulos JA West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285 [TBL] [Abstract][Full Text] [Related]
12. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin. Nishino T; Tubb J; Emery DW Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578 [TBL] [Abstract][Full Text] [Related]
13. Current status of globin gene therapy for the treatment of beta-thalassaemia. Lisowski L; Sadelain M Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569 [TBL] [Abstract][Full Text] [Related]
14. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy. Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280 [TBL] [Abstract][Full Text] [Related]
15. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach. Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease. Yannaki E; Stamatoyannopoulos G Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773 [TBL] [Abstract][Full Text] [Related]